ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag grant writing disease medicine

Two sets of identical twin children sitting
Identical Twins Carry Distinctive Epigenetic Marks: Study
Chloe Tenn | Sep 30, 2021 | 2 min read
Researchers found more than 800 sites in the genome where the twins bore the same chemical tags.
Image of the tissue surrounding a pancreatic tumor thickening and scarring.
How Pancreas Injuries Can Cause Cancer in Mice
Dan Robitzski | Nov 9, 2021 | 4 min read
A key mutation turns healing cells into cancer promoters.
Johnson Grants Let Scientists Take Risks
Paul Kefalides | Oct 25, 1992 | 5 min read
In 1989, when Harvard University geneticist Rachael Neve sought funding to test her controversial hypothesis on Alzheimer's disease, her requests fell on deaf ears. "I had been writing a proposal to [the National Institutes of Health] for a year and a half, and it kept getting rejected," recalls Neve, who challenged the conventional wisdom in neuroscience with data indicating that the toxic protein responsible for Alzheimer's was some 60 amino acids longer than previously thought. "I applied to
Alternative Medicines
The Scientist | Jul 1, 2012 | 10+ min read
As nonconventional medical treatments become increasingly mainstream, we take a look at the science behind some of the most popular.
A Winning Strategy For Grant Applications: Focus On Impact
Kathryn Brown | Apr 27, 1997 | 8 min read
Sidebar: The Dos and Don'ts of Winning Dollars Sidebar: Grant Writing - For More Information A NEW STRATEGY: UC-Irvine’s Keith Woerpel, who revised his rejected grant applications to focus on impact, now has several grants. To Keith Woerpel, 1994 will forever be the year he learned to write grants-the hard way. An assistant professor of chemistry at the University of California, Irvine, Woerpel wrote five grant applications that year. All were rejected. "I was getting burned really badly
Follow the Funding
Bob Grant | May 1, 2015 | 7 min read
In times of budget belt-tightening at the federal level, life-science researchers can keep their work supported through private sources.
 
Rewards of Risk
Megan Scudellari | Feb 1, 2011 | 7 min read
Secrets to scoring big money grants for innovative, out-of-the-box research
Open orange pill bottle with rounded white pills
What’s the Evidence for Fluvoxamine in COVID-19? 
Catherine Offord | May 20, 2022 | 7 min read
The US FDA’s decision not to grant an emergency use authorization for the antidepressant as a COVID-19 treatment highlights a lack of consensus among researchers about how to interpret clinical data on the drug.
RSV vaccine design concept art
RSV Vaccines That Work?
Rachael Moeller Gorman | Feb 16, 2023 | 10+ min read
Multiple candidates are in Phase 3 clinical trials for older adults and pregnant women, with some getting close to approval in the United States.
Bristol-Myers' Unrestricted Grants Fund Neuroscientists' 'Wildest Ideas'
Barbara Spector | Oct 29, 1989 | 4 min read
Why would a major pharmaceutical company like Bristol-Myers give half a million dollars to a neuroscientist without requiring him to submit a grant application? And why would the grant be unrestricted, with no spending guidelines? Why wouldn’t the principal investigator be required to offer the company first right of refusal to any patent resulting from the research—or even to write up periodic reports? “It’s seed money for good science,” says Davis L. Temple, Jr

Run a Search

ADVERTISEMENT